ADMA Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0.13 | $0.08 | 62.5 % |
Mar 2024 | 2024-05-09 | $0.08 | $0.05 | 60.0 % |
Dec 2023 | 2024-02-28 | $0.04 | $0.02 | 100.0 % |
Sep 2023 | 2023-11-08 | $0.01 | $-0.01 | 200.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $107.19M | $86.41M | 24.1 % |
Mar 2024 | 2024-05-09 | $81.88M | $77.27M | 5.96 % |
Dec 2023 | 2024-02-28 | $73.90M | $72.15M | 2.43 % |
Sep 2023 | 2023-11-08 | $67.28M | $62.12M | 8.30 % |
ADMA Biologics (ADMA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $0.13, which beat the estimate of $0.08.
The Actual Revenue was $107.2M, which beat the estimate of $86.4M.
Browse earnings estimates, EPS, and revenue on all stocks.